15-Keto Prostaglandin E0

Hersteller Toronto Research Chemicals
Typ Biochemicals
Specific against other
Menge 5mg
ArtNr TRC-K202055-5mg
eClass 6.1 32160405
eClass 9.0 32160490
(11alpha)-11-Hydroxy-9, 15-dioxo-prostan-1-oic Acid; 3-Hydroxy-5-oxo-2-(3-oxooctyl)-cyclopentaneheptanoic Acid; 3-Hydroxy-5-oxo-2-(3-oxooctyl)-cyclopentaneheptanoic Acid Stereoisomer; 11alpha-Hydroxy-9, 15-diketoprostanoic Acid; 11alpha-Hydroxy-9, 15-dioxoprostanoic Acid; 13, 14-Dihydro-15-keto-PGE1; 13, 14-Dihydro-15-keto-PGE1; 13, 14-Dihydro-15-ketoprostaglandin E1; 13, 14-Dihydro-15-oxo-PGE1; 15-Oxodihydroprostaglandin E1; 15-keto-13, 14-Dihydro-PGE1; 15-keto-13, 14-Dihydroprostaglandin E1; Dihydro-15-ketoprostaglandin E1; U 21002
CAS Number
Mol. Formula
Mol. Weight
354, 48
Melting Pt.
No Data Available
Application Notes
15-Keto Prostaglandin E0 is a metabolite of Prostaglandin E1 (P838600) and has been shown to induce arterial thromboresistance in experimental animals and in man, but with several magnitudes higher concentrations than Prostaglandin E1. 15-Keto Prostaglandin E0 is also used as the active ingredient in compositions used for the treatment of external secretion disorders.
Sinzinger, H., et al.: Prostag. Oth. Lipid M., 55, 265 (1998); Ueno, R. PCT Int. Appl. WO 2001005388 A2 20010125. Jan 25, 2001
Menge: 5mg
Lieferbar: Out of stock
nicht lieferbar

fragen Sie nach einem alternativen Produkt

Fragen zum Produkt?